Posted by notfred on October 3, 2006, at 20:48:57
In reply to QoL: Old versus atypical antipsychotics, posted by ed_uk on October 3, 2006, at 16:18:42
Conclusions In people with schizophrenia whose medication is changed for clinical reasons, there is no disadvantage across 1 year in terms of quality of life, symptoms, or associated costs of care in using FGAs rather than nonclozapine SGAs. Neither inadequate power nor patterns of drug discontinuation accounted for the result.
Hmmm, seems to me that the atypicals have not been around long enough to show their negatives, ie movement disorders. It can take decades for TD to show itself, given that AP's both cause and suppress movement disorders. AP's that suppress movement disorders are likely to cause them. Till people have been on atypicals for decades I do not think it is healthy to say they are less likely to cause movement disorders. Nor is there any proof, as people have not been on them long enough, that low doses are safer. It is wishful thinking.
At the same time 1 year is but a drop in a bucket
for schizophrenia.
poster:notfred
thread:691556
URL: http://www.dr-bob.org/babble/20061003/msgs/691636.html